SCHEMBL7195693

SCHEMBL7195693

COc1cc(C=CC(=O)c2c(OC)c(OC)cc(OC)c2OC)c(OC)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 8/20 0.56
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
MAPT P10636 3/20 0.49
TNFRSF1A P19438 2/20 0.49
NFKB1 P19838 1/20 0.49
DPP4 P27487 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
CYP19A1 P11511 1/20 0.49
CYP3A4 P08684 2/20 0.48
KMT2A Q03164 2/20 0.48
TP53 P04637 1/20 0.48
ATM Q13315 1/20 0.48
HSD17B10 Q99714 1/20 0.48
AURKA O14965 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195677 1.00 ABCG2 (0.56) ABCG2MAOAMAOBPDE4APDE4B
SCHEMBL7194891 0.90 ABCG2 (0.56) ABCG2MAOAMAOBPDE4APDE4B
SCHEMBL7194897 0.90 ABCG2 (0.56) ABCG2MAOAMAOBPDE4APDE4B
SCHEMBL28064281 0.87 MAOA (0.70) ABCG2MAOAMAOBMAPTNFKB1
SCHEMBL28064283 0.87 MAOA (0.70) ABCG2MAOAMAOBMAPTNFKB1
SCHEMBL7196690 0.86 ABCG2 (0.70) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7196695 0.86 ABCG2 (0.70) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7194483 0.85 PDE4A (0.58) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7194479 0.85 PDE4A (0.58) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL2744068 0.84 MAPT (0.64) ABCG2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 EP claimed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 ABCG2 1177/4885MAOA 904/4885MAOB 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.